Impact of COVID-19 on Renal Dysfunction
Israa Hashim Saadoon*
Professor, Department of Microbiology, College of Medicine, Tikrit University, Iraq
*Corresponding Author: Israa Hashim Saadoon, Professor, Department of Microbiology, College of Medicine, Tikrit University, Iraq.
November 25, 2022; Published: January 01, 2023
Coronavirus Disease-2019 (COVID-19) may cause different degrees of renal impairment . One of the studies conducted on hemodialysis patients and infected with COVID-19 revealed that there was no difference between patients regarding the presence or absence of diabetes mellitus and hypertension, but the effect of COVID-19 on the kidney increased with increasing the age .
- Parise RS., et al. “COVID-19 induced renal injury differs from that in other viral-infections”. Emergency and Critical Care Medicine 1 (2022): 23-31.
- Alhashmi AA., et al. “The effects of SARS-CoV-2 infection on renal function in patients with hemodialysis”. Bahrain Medical Bulletin, September 44.3 (2022): 1056-1059.
- Copur S., et al. “Post acute COVID 19 syndrome and kidney diseases: what do we know?”. Journal of Nephrology 35 (2022): 795–805.
- Kenneth J Ryan. “Sherries and Ryan’s Medical Microbiology””. 8th McGrowHil (2022).
- Axenciuc P., et al. “Pathomorphology of kidney damage in Covid-19: Possible etiological factors”. Journal of Clinical Nephrology and Renal Care 2 (2022): 073.
- Xiaoying Gu., et al. “Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study”. eBioMedicine 76 (2022): 103817.
- Chih-Yun Yang., et al. “The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection”. International Journal of Medical Sciences 19 (2022): 1340- 1356.
- Liu C., et al. “Kidney diseases and long non-coding RNAs in the limelight”. Frontiers in Physiology Type Review Published 10 October (2022): 1-20.
- Zhao Q., et al. “Identification of a SARS-CoV-2 virus-encoded small noncoding RNA in association with the neurological disorders in COVID-19 patients”. Signal Transduction and Targeted Therapy 7 (2022): 107.
- Yang C., et al. “The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection”. International Journal of Medical Sciences 8 (2022): 1340-1356.
- Tayel SI., et al. “Interplay of LncRNAs NEAT1 and TUG1 in incidence of cytokine storm in appraisal of COVID-19 infection”. International Journal of Biological Sciences 18 (2022).
- Metzinger L., et al. “The role of non-coding RNAs in kidney diseases”. International Journal of Medical Sciences 23 (2022): 6624.